Patent · US Expired

Peptides with immunomodulatory effects

US6228374A · kind A · utility

4Cited by
3References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 1, 2000
Grant dateMay 8, 2001
Priority date
Expiry dateMay 1, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel homodimers that include cysteine-containing peptides having 4-15 amino acid residues can be administered to modulate the immune response in an animal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.